US20190062801A1 - Systems and methods for electrochemical aspartate transaminase (ast) and alanine transaminase (alt) detection and quantification - Google Patents
Systems and methods for electrochemical aspartate transaminase (ast) and alanine transaminase (alt) detection and quantification Download PDFInfo
- Publication number
- US20190062801A1 US20190062801A1 US16/176,056 US201816176056A US2019062801A1 US 20190062801 A1 US20190062801 A1 US 20190062801A1 US 201816176056 A US201816176056 A US 201816176056A US 2019062801 A1 US2019062801 A1 US 2019062801A1
- Authority
- US
- United States
- Prior art keywords
- sampler
- alt
- ast
- test strip
- electrochemical
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 102100036475 Alanine aminotransferase 1 Human genes 0.000 title description 49
- 108010082126 Alanine transaminase Proteins 0.000 title description 49
- 108010003415 Aspartate Aminotransferases Proteins 0.000 title description 48
- 102000004625 Aspartate Aminotransferases Human genes 0.000 title description 48
- 238000000034 method Methods 0.000 title description 7
- 238000001514 detection method Methods 0.000 title description 4
- 238000011002 quantification Methods 0.000 title description 2
- 238000000840 electrochemical analysis Methods 0.000 claims abstract description 34
- LCTONWCANYUPML-UHFFFAOYSA-M Pyruvate Chemical compound CC(=O)C([O-])=O LCTONWCANYUPML-UHFFFAOYSA-M 0.000 claims abstract description 25
- 229910019142 PO4 Inorganic materials 0.000 claims description 14
- 108010042687 Pyruvate Oxidase Proteins 0.000 claims description 14
- 239000010452 phosphate Substances 0.000 claims description 14
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims description 13
- 238000010438 heat treatment Methods 0.000 claims description 10
- YAGKRVSRTSUGEY-UHFFFAOYSA-N ferricyanide Chemical compound [Fe+3].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-] YAGKRVSRTSUGEY-UHFFFAOYSA-N 0.000 claims description 7
- KPGXRSRHYNQIFN-UHFFFAOYSA-L 2-oxoglutarate(2-) Chemical compound [O-]C(=O)CCC(=O)C([O-])=O KPGXRSRHYNQIFN-UHFFFAOYSA-L 0.000 claims description 6
- 108010017192 4-hydroxy-4-methyl-2-oxoglutarate aldolase Proteins 0.000 claims description 4
- 102100029589 Acylpyruvase FAHD1, mitochondrial Human genes 0.000 claims description 4
- 108010069823 Oxaloacetate decarboxylase Proteins 0.000 claims description 4
- CKLJMWTZIZZHCS-UHFFFAOYSA-N D-OH-Asp Natural products OC(=O)C(N)CC(O)=O CKLJMWTZIZZHCS-UHFFFAOYSA-N 0.000 claims description 3
- QNAYBMKLOCPYGJ-UHFFFAOYSA-N D-alpha-Ala Natural products CC([NH3+])C([O-])=O QNAYBMKLOCPYGJ-UHFFFAOYSA-N 0.000 claims description 3
- QNAYBMKLOCPYGJ-UWTATZPHSA-N L-Alanine Natural products C[C@@H](N)C(O)=O QNAYBMKLOCPYGJ-UWTATZPHSA-N 0.000 claims description 3
- CKLJMWTZIZZHCS-UWTATZPHSA-N L-Aspartic acid Natural products OC(=O)[C@H](N)CC(O)=O CKLJMWTZIZZHCS-UWTATZPHSA-N 0.000 claims description 3
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 claims description 3
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 claims description 3
- 229960003767 alanine Drugs 0.000 claims description 3
- 229960005261 aspartic acid Drugs 0.000 claims description 3
- 238000003556 assay Methods 0.000 description 24
- 238000006243 chemical reaction Methods 0.000 description 22
- 238000012360 testing method Methods 0.000 description 22
- 239000008280 blood Substances 0.000 description 10
- 210000004369 blood Anatomy 0.000 description 10
- 239000000376 reactant Substances 0.000 description 6
- 210000004185 liver Anatomy 0.000 description 5
- 230000037361 pathway Effects 0.000 description 5
- 238000005070 sampling Methods 0.000 description 5
- 240000005020 Acaciella glauca Species 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 4
- 241000588724 Escherichia coli Species 0.000 description 4
- 239000003153 chemical reaction reagent Substances 0.000 description 4
- 239000012528 membrane Substances 0.000 description 4
- 235000003499 redwood Nutrition 0.000 description 4
- 230000008569 process Effects 0.000 description 3
- MHAJPDPJQMAIIY-UHFFFAOYSA-N OO Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- 229930003316 Vitamin D Natural products 0.000 description 2
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 2
- 239000012491 analyte Substances 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000007812 electrochemical assay Methods 0.000 description 2
- 230000005518 electrochemistry Effects 0.000 description 2
- 238000005562 fading Methods 0.000 description 2
- 208000019423 liver disease Diseases 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 238000002483 medication Methods 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000005457 optimization Methods 0.000 description 2
- 239000008363 phosphate buffer Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 235000019166 vitamin D Nutrition 0.000 description 2
- 239000011710 vitamin D Substances 0.000 description 2
- 150000003710 vitamin D derivatives Chemical class 0.000 description 2
- 229940046008 vitamin d Drugs 0.000 description 2
- 0 *S[3H].O=C=O.OO Chemical compound *S[3H].O=C=O.OO 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 208000005176 Hepatitis C Diseases 0.000 description 1
- 206010034960 Photophobia Diseases 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 238000010241 blood sampling Methods 0.000 description 1
- BRPQOXSCLDDYGP-UHFFFAOYSA-N calcium oxide Chemical compound [O-2].[Ca+2] BRPQOXSCLDDYGP-UHFFFAOYSA-N 0.000 description 1
- 239000000292 calcium oxide Substances 0.000 description 1
- ODINCKMPIJJUCX-UHFFFAOYSA-N calcium oxide Inorganic materials [Ca]=O ODINCKMPIJJUCX-UHFFFAOYSA-N 0.000 description 1
- 230000005779 cell damage Effects 0.000 description 1
- 230000030833 cell death Effects 0.000 description 1
- 208000037887 cell injury Diseases 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000004737 colorimetric analysis Methods 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 230000000881 depressing effect Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000000835 electrochemical detection Methods 0.000 description 1
- 238000003487 electrochemical reaction Methods 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 210000003494 hepatocyte Anatomy 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 208000013469 light sensitivity Diseases 0.000 description 1
- 238000013332 literature search Methods 0.000 description 1
- 210000005229 liver cell Anatomy 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 238000012123 point-of-care testing Methods 0.000 description 1
- 229920005596 polymer binder Polymers 0.000 description 1
- 239000002491 polymer binding agent Substances 0.000 description 1
- -1 potassium ferricyanide Chemical compound 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 210000002027 skeletal muscle Anatomy 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
- C12Q1/52—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase involving transaminase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0008—Oxidoreductases (1.) acting on the aldehyde or oxo group of donors (1.2)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/88—Lyases (4.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/001—Enzyme electrodes
- C12Q1/005—Enzyme electrodes involving specific analytes or enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y102/00—Oxidoreductases acting on the aldehyde or oxo group of donors (1.2)
- C12Y102/03—Oxidoreductases acting on the aldehyde or oxo group of donors (1.2) with oxygen as acceptor (1.2.3)
- C12Y102/03003—Pyruvate oxidase (1.2.3.3)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y401/00—Carbon-carbon lyases (4.1)
- C12Y401/01—Carboxy-lyases (4.1.1)
- C12Y401/01003—Oxaloacetate decarboxylase (4.1.1.3)
Definitions
- the AST/ALT ratio is the ratio between the concentrations of the enzymes aspartate transaminase (AST) and alanine transaminase (ALT).
- AST and ALT relate to the health of an individual's liver. These enzymes are found in the blood of individuals. If the AST measurement is lower than the ALT measurement, it is generally suggestive of some sort of liver disease, especially those caused by alcohol. Hepatitis C or other liver diseases may also result in an imbalance in the levels of AST and ALT. It is desirable to have a point-of-care test to test for these analytes.
- a system for electrochemically detecting AST includes a sampler for producing pyruvate from AST; an electrochemical test strip for receiving a processed sample from the sampler, the processed sample containing pyruvate; and a meter for reading the electrochemical test strip and indicating an amount of AST in the sample.
- the sampler contains L-Alanine+alpha-Ketoglutarate.
- the electrochemical test strip includes phosphate and ferricyanide.
- the electrochemical test strip further includes pyruvate oxidase.
- the sampler includes a heating element.
- the sampler includes a timer.
- the meter includes a timer.
- a system for electrochemically detecting ALT includes a sampler for producing pyruvate from ALT; an electrochemical test strip for receiving a processed sample from the sampler, the processed sample containing pyruvate; and a meter for reading the electrochemical test strip and indicating an amount of ALT in the sample.
- the sampler contains L-Aspartic acid+alpha-Ketoglutarate.
- the sampler further contains oxaloacetate decarboxylase.
- the electrochemical test strip includes phosphate and ferricyanide.
- the electrochemical test strip further includes pyruvate oxidase.
- the sampler includes a heating element.
- the sampler includes a timer.
- the meter includes a timer.
- the electrochemical test strip contains a heating element to heat the sample using the meter as a source of energy.
- a system for electrochemically detecting AST and ALT includes a first sampler for producing pyruvate from AST and a second sampler for producing pyruvate from ALT.
- the system further includes an electrochemical test strip for receiving processed samples from the first and second samplers, the processed samples containing pyruvate.
- the system further includes a meter for reading the electrochemical test strip and indicating an amount of AST and ALT in the sample.
- the first sampler contains L-Alanine+alpha-Ketoglutarate.
- the second sampler contains L-Aspartic acid+alpha-Ketoglutarate.
- the second sampler further contains oxaloacetate decarboxylase.
- the electrochemical test strip further contains oxaloacetate decarboxylase.
- the electrochemical test strip includes phosphate, pyruvate oxidase, and ferricyanide.
- a system for electrochemically detecting phosphate includes an electrochemical test strip for receiving a sample; the electrochemical test strip includes pyruvate, pyruvate oxidase, and ferricyanide; and a meter for reading the electrochemical test strip and indicating an amount of phosphate in the sample.
- FIG. 1 shows the standard point-of-care colorimetric ALT reaction
- FIG. 2 shows a proof-of-concept graph was conducted without any optimization of reagents
- FIGS. 3 a -3 c show one embodiment of a sample collector (Redwood Sampler) containing reactants for reacting with ALT or AST;
- FIG. 4 shows one embodiment of an electrochemical test strip for receiving a sample from the sampler of FIGS. 3 a - 3 c;
- FIG. 5 shows that ALT and AST tests can be combined as a joint test strip and shows one embodiment of such a strip
- FIG. 6 shows an embodiment with a single sampling port
- FIG. 7 shows an embodiment of strip with a receiving port for a sampler.
- ALT and AST assays Disclosed are embodiments of ALT and AST assays.
- One of the challenges of colormetric assays has been the temperamental nature of chromogens on membranes. It is necessary to have a highly sensitive chromophore in order to test for ALT or AST.
- Some challenges with chromophores are fading during the reaction, instability in the compounding process, light sensitivity, insolubility, and limited by pH ranges.
- One method and system for overcoming these shortcomings is that these assays could be developed using electrochemistry. By going to an electrochemical assay, it eliminates any need for a chromophore.
- ALT and AST are enzymes primarily associated with the liver. AST primarily is found in the liver, heart, and skeletal muscles, while ALT primarily is found in the liver. The release of ALT and AST from liver cells to the blood stream is an indication of hepatic cell damage or death. There are various medical reasons an ALT or AST test would be recommended. In a point-of-care setting, such assays may be used to monitor patients who are taking medications that may cause adverse effects on the liver.
- Embodiments described herein provide a novel reaction pathway to conduct an electrochemical ALT and AST assay. Once pyruvate is produced, the reaction is the same for both the ALT and AST reactions. We have discovered through literature searches and empirically that pyruvate oxidase specifically from E. Coli will react directly with a mediator that will be reduced at the electrode. This provides for an electrochemical reaction.
- FIG. 1 shows the standard point-of-care colorimetric ALT reaction. This reaction and the similar AST reaction have significant issues with the sensitivity of membranes and chromophores.
- FIG. 2 shows a proof-of-concept graph was conducted without any optimization of reagents.
- phosphate pyruvate oxidase from E. Coli
- potassium ferricyanide potassium ferricyanide
- co-factors co-factors
- polymer binder an electrochemical sensor was made to measure pyruvate. In approximately ten seconds of time, pyruvate was able to be measured amperometrically (see FIG. 2 ).
- this time is tracked on the meter by depressing a button or giving another indication to the meter when the sample is added. After the given amount of time, the strip would be dosed by the sampler contents.
- inside the sampler it is possible to create an exothermic reaction by using calcium oxide, sodium acetate, or any such chemicals to add heat to the reaction. By adding heat, the ALT and AST reaction will occur more quickly.
- the meter may apply heat or an electrical heating element may be included in the sampler.
- the electrochemical test strip contains a heating element to heat the sample using the meter as a source of energy.
- FIGS. 3 a -3 c show one embodiment of a sample collector (Redwood Sampler) containing reactants for reacting with ALT or AST.
- a capillary tube system for taking a blood sample is shown.
- FIG. 3 b shows the method of obtaining a blood sample using the capillary tube system.
- FIG. 3 c shows the capillary tube system after it has been inserted in a receiver. This receiver carries the chemicals for the reaction described above. Additionally, the receiver may include a heating element as described, as well as a timer (however, these elements may be located in the capillary tube sampler as well).
- FIG. 4 shows one embodiment of an electrochemical test strip for receiving a sample from the sampler of FIGS. 3 a -3 c .
- a receiving port 410 is provided for receiving a sample from the sampler.
- a fill detection electrode 420 may be provided.
- an electrode 430 and counter electrode 440 are provided.
- a versatile electrochemical test strip and offer multiple tests on the same strip.
- the figures below show an embodiment with multiple blood application sites. However, this in some embodiments, the system has a single blood application site.
- FIG. 5 shows that ALT and AST tests can be combined as a joint test. In addition, other tests may be combined with ALT and AST such as glucose and ketones.
- FIG. 5 shows one embodiment of the strip design. Shown are four strips 10 . From left to right, the strips 10 have 4, 3, 2, and 1 sample receiving ports 20 . Each sample receiving port may have an electrode 30 , a counter electrode 40 , and a reference electrode 50 . The reference electrode 50 may provide for a fill indication, as it will only pass a voltage when the sample reaches the electrode 50 .
- the contacts 70 , 80 are also visible, which interconnect with the electrodes and connect to contacts in the meter when inserted. The strip size does not change depending on the number of assays.
- FIG. 5 shows that ALT and AST tests can be combined as a joint test. In addition, other tests may be combined with ALT and AST such as glucose and ketones.
- FIG. 5 shows one embodiment of the strip design. Shown are four strips 10 . From left to right, the
- FIG. 5 displays a separate blood sampling port for each assay. Some embodiments may include separate sampling ports, particularly if there could be “cross talk” between reagents.
- FIG. 6 shows an embodiment with a single sampling port. In many embodiments, there will be a singular sampling port 210 for the multi-analyte panels. Again, this strip allows for adaptability of design to meet the needs of particular assays. As shown in the left-most strip, a single sample port 210 may provide for five different sets of contacts, providing for the testing of five different analyte tests. Various combinations of analytes may be used in the strips as described herein. In some embodiments, a central application point is available for the sampler. This eases the challenge of dosing a large number of ports.
- Test strip 710 includes a receiving port 720 , similar to receiving port 410 of FIG. 4 .
- the receiving port 720 is sized in a complementary fashion to that of a sampler that may include a premix set.
- the receiving port 720 includes tubes 730 (typically capillary tubes) for extracting a portion of the sample. Also shown are the contact wires 740 , the connect to the electrodes that are typically located in the tubes 730 .
- the arrangement shown is only one possible arrangement for a receiving port with multiple interconnected capillary channels. A large number of geometries are possible.
- the receiving port 720 may include a first and second set point.
- the sample When the sampler is inserted and pushed to the first set point in the receiving port 720 , the sample may be distributed to the tubes 730 . After distribution, the sampler may be further advanced to separate the sampler from the sample contained in the tubes 730 .
- receiving port may include breakaway tabs at the first set point through which the user may push the sampler, in order to reach the second set point, whereby fluidic communication between the sample in the tubes is lessened. This may decrease cross talk.
- the pyruvate reaction pathway may apply to the detection of other analytes as well. For instance, in one embodiment, this phosphate may react in a similar fashion.
- the pyruvate reaction where pyruvate oxidase from E. Coli reacts with the mediator for an electrochemical ALT and AST assay (see reaction below) can be used for an electrochemical detection scheme.
- an electrochemical phosphate assay By providing the pyruvate, ferricyanide, and pyruvate oxidase, one can easily develop an electrochemical phosphate assay.
- a phosphate assay would be an excellent companion assay with a Vitamin D test. It also could be used in a non-medical application in water testing.
- One challenge is that many pyruvate oxidase enzymes have been lyophilized from a phosphate buffer. A pyruvate oxidase enzyme that is not provided in a phosphate buffer is needed in some embodiments to complete this assay.
- an electrochemical ALT, AST, and phosphate sensor are provided herein.
- An electrochemical point-of-care ALT/AST test does not previously exist.
- the ALT and AST tests could be beneficial to those taking medications which could possibly impair liver function. It also may be used in small clinics to determine levels of ALT or AST for further medical diagnosis.
- having an electrochemical phosphate assay could be used as a companion diagnostic to a Vitamin D assay or a stand-alone test.
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Hematology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Electrochemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
Abstract
A system for electrochemically detecting AST and ALT includes a first sampler for producing pyruvate from ALT and a second sampler for producing pyruvate from AST. The system further includes an electrochemical test strip for receiving processed samples from the first and second samplers, the processed samples containing pyruvate. The system further includes a meter for reading the electrochemical test strip and indicating an amount of AST and ALT in the sample.
Description
- This application is a divisional of U.S. application Ser. No. 15/392,593, filed Dec. 28, 2016, which claims the benefit of U.S. Provisional Patent Application 62,271,753 filed Dec. 28, 2015, the disclosures of which are hereby incorporated by reference.
- The AST/ALT ratio is the ratio between the concentrations of the enzymes aspartate transaminase (AST) and alanine transaminase (ALT). Generally, AST and ALT relate to the health of an individual's liver. These enzymes are found in the blood of individuals. If the AST measurement is lower than the ALT measurement, it is generally suggestive of some sort of liver disease, especially those caused by alcohol. Hepatitis C or other liver diseases may also result in an imbalance in the levels of AST and ALT. It is desirable to have a point-of-care test to test for these analytes.
- In one embodiment, a system for electrochemically detecting AST includes a sampler for producing pyruvate from AST; an electrochemical test strip for receiving a processed sample from the sampler, the processed sample containing pyruvate; and a meter for reading the electrochemical test strip and indicating an amount of AST in the sample. In one configuration, the sampler contains L-Alanine+alpha-Ketoglutarate. In another configuration, the electrochemical test strip includes phosphate and ferricyanide. Optionally, the electrochemical test strip further includes pyruvate oxidase. In one alternative, the sampler includes a heating element. In another alternative, the sampler includes a timer. Alternatively, the meter includes a timer.
- In one embodiment, a system for electrochemically detecting ALT includes a sampler for producing pyruvate from ALT; an electrochemical test strip for receiving a processed sample from the sampler, the processed sample containing pyruvate; and a meter for reading the electrochemical test strip and indicating an amount of ALT in the sample. In one configuration, the sampler contains L-Aspartic acid+alpha-Ketoglutarate. In another configuration, the sampler further contains oxaloacetate decarboxylase. Optionally, the electrochemical test strip includes phosphate and ferricyanide. Alternatively, the electrochemical test strip further includes pyruvate oxidase. In one configuration, the sampler includes a heating element. Optionally, the sampler includes a timer. Alternatively, the meter includes a timer. In another configuration, the electrochemical test strip contains a heating element to heat the sample using the meter as a source of energy.
- In one embodiment, a system for electrochemically detecting AST and ALT includes a first sampler for producing pyruvate from AST and a second sampler for producing pyruvate from ALT. The system further includes an electrochemical test strip for receiving processed samples from the first and second samplers, the processed samples containing pyruvate. The system further includes a meter for reading the electrochemical test strip and indicating an amount of AST and ALT in the sample. Optionally, the first sampler contains L-Alanine+alpha-Ketoglutarate. Alternatively, the second sampler contains L-Aspartic acid+alpha-Ketoglutarate. In one configuration, the second sampler further contains oxaloacetate decarboxylase. In one configuration, the electrochemical test strip further contains oxaloacetate decarboxylase. In another configuration, the electrochemical test strip includes phosphate, pyruvate oxidase, and ferricyanide.
- In one embodiment, a system for electrochemically detecting phosphate includes an electrochemical test strip for receiving a sample; the electrochemical test strip includes pyruvate, pyruvate oxidase, and ferricyanide; and a meter for reading the electrochemical test strip and indicating an amount of phosphate in the sample.
-
FIG. 1 shows the standard point-of-care colorimetric ALT reaction; -
FIG. 2 shows a proof-of-concept graph was conducted without any optimization of reagents; -
FIGS. 3a-3c show one embodiment of a sample collector (Redwood Sampler) containing reactants for reacting with ALT or AST; -
FIG. 4 shows one embodiment of an electrochemical test strip for receiving a sample from the sampler ofFIGS. 3a -3 c; -
FIG. 5 shows that ALT and AST tests can be combined as a joint test strip and shows one embodiment of such a strip; -
FIG. 6 shows an embodiment with a single sampling port; and -
FIG. 7 shows an embodiment of strip with a receiving port for a sampler. - Certain terminology is used herein for convenience only and is not to be taken as a limitation on the embodiments of the systems and methods for electrochemical aspartate transaminase (AST) and alanine transaminase (ALT) detection and quantification. In the drawings, the same reference letters are employed for designating the same elements throughout the several figures.
- Disclosed are embodiments of ALT and AST assays. One of the challenges of colormetric assays has been the temperamental nature of chromogens on membranes. It is necessary to have a highly sensitive chromophore in order to test for ALT or AST. Some challenges with chromophores are fading during the reaction, instability in the compounding process, light sensitivity, insolubility, and limited by pH ranges. One method and system for overcoming these shortcomings is that these assays could be developed using electrochemistry. By going to an electrochemical assay, it eliminates any need for a chromophore. Some advantages include:
-
- 1. By having an amperometric ALT and AST assay, no membranes are necessary. This provides for a cheaper manufacturing process and avoids being at the mercy of membrane manufacturers' ability to produce reliable, consistent product.
- 2. Calibration of the analyzer is easier with electrochemical testing. Measuring current (nA) is a standardized process, whereas standardizing reflectance is more difficult.
- 3. Because the ALT and AST assays are measuring enzymes, the time of testing is longer than most assays. This becomes problematic for colorimetric tests because many chromophores display fading over time, particularly in a heated environment. By testing ALT and AST in an electrochemical environment, there is no need for a chromophore.
- 4. Electrochemical test strips generally are inexpensive to produce due to the automation and small amounts of reagent used.
- 5. Testing ALT and AST via electrochemistry probably will result in better precision.
- 6. In many embodiments, the test range of ALT and AST could be larger than a reflectance assay. Reflectance assays are limited by the amount of color that is produced, whereas electrochemical assays are not limited by the current produced.
- 7. In many embodiments, the sample size will be small: ˜1.2 μL instead of 15 μL.
- 8. In many embodiments, there may be no need of a transfer pipette to apply blood to a strip since the blood sample is simply wicked into the sampling port.
- Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) are enzymes primarily associated with the liver. AST primarily is found in the liver, heart, and skeletal muscles, while ALT primarily is found in the liver. The release of ALT and AST from liver cells to the blood stream is an indication of hepatic cell damage or death. There are various medical reasons an ALT or AST test would be recommended. In a point-of-care setting, such assays may be used to monitor patients who are taking medications that may cause adverse effects on the liver.
- Embodiments described herein provide a novel reaction pathway to conduct an electrochemical ALT and AST assay. Once pyruvate is produced, the reaction is the same for both the ALT and AST reactions. We have discovered through literature searches and empirically that pyruvate oxidase specifically from E. Coli will react directly with a mediator that will be reduced at the electrode. This provides for an electrochemical reaction.
-
- Proposed electrochemical AST Reaction Pathway:
- Most ALT/AST reaction pathways that use pyruvate oxidase require the use of oxygen and react the peroxide formed with a chromophore. This process takes an additional reaction step than what is proposed. Furthermore, the journal articles and papers on proposed electrochemical ALT/AST assays also make use of the additional peroxide-peroxidase reaction step. We have shown that we can eliminate this peroxide-peroxidase step by using a pyruvate oxidase from E. Coli which reacts directly with the mediator. In theory, by eliminating reaction steps, the precision and speed of the assay should improve.
-
FIG. 1 shows the standard point-of-care colorimetric ALT reaction. This reaction and the similar AST reaction have significant issues with the sensitivity of membranes and chromophores. - Proof of concept has been shown for an electrochemical ALT and AST assay by measuring pyruvate amperometrically.
FIG. 2 shows a proof-of-concept graph was conducted without any optimization of reagents. Using phosphate, pyruvate oxidase from E. Coli, potassium ferricyanide, co-factors, and polymer binder, an electrochemical sensor was made to measure pyruvate. In approximately ten seconds of time, pyruvate was able to be measured amperometrically (seeFIG. 2 ). - By showing an electrochemical pyruvate reaction, it is only a matter of reacting the ALT and AST with their reactants to produce pyruvate. This may be done in a number of different ways. One embodiment would be to have all components reacted on the electrochemical test strip. Another approach may be to involve a sample shaker like a “Redwood sampler” which contains the reactants that will react with the enzymes (ALT or AST) to produce pyruvate. In this embodiment, there is a timer started when the blood was allowed to mix with the reactants. In some embodiments, when the blood is introduced to the reactants, pushing the parts together on the Redwood sampler would start a timer on the sampler. In other embodiments, this time is tracked on the meter by depressing a button or giving another indication to the meter when the sample is added. After the given amount of time, the strip would be dosed by the sampler contents. In some embodiments, inside the sampler, it is possible to create an exothermic reaction by using calcium oxide, sodium acetate, or any such chemicals to add heat to the reaction. By adding heat, the ALT and AST reaction will occur more quickly. Alternatively, the meter may apply heat or an electrical heating element may be included in the sampler. In another configuration, the electrochemical test strip contains a heating element to heat the sample using the meter as a source of energy.
-
FIGS. 3a-3c show one embodiment of a sample collector (Redwood Sampler) containing reactants for reacting with ALT or AST. InFIG. 3a , a capillary tube system for taking a blood sample is shown.FIG. 3b shows the method of obtaining a blood sample using the capillary tube system.FIG. 3c shows the capillary tube system after it has been inserted in a receiver. This receiver carries the chemicals for the reaction described above. Additionally, the receiver may include a heating element as described, as well as a timer (however, these elements may be located in the capillary tube sampler as well). -
FIG. 4 shows one embodiment of an electrochemical test strip for receiving a sample from the sampler ofFIGS. 3a-3c . In thisstrip 400, a receivingport 410 is provided for receiving a sample from the sampler. Afill detection electrode 420 may be provided. Additionally, anelectrode 430 andcounter electrode 440 are provided. - In addition to having a single electrochemical ALT or AST sensor, in some embodiments, a versatile electrochemical test strip and offer multiple tests on the same strip. The figures below show an embodiment with multiple blood application sites. However, this in some embodiments, the system has a single blood application site.
-
FIG. 5 shows that ALT and AST tests can be combined as a joint test. In addition, other tests may be combined with ALT and AST such as glucose and ketones.FIG. 5 shows one embodiment of the strip design. Shown are fourstrips 10. From left to right, thestrips 10 have 4, 3, 2, and 1 sample receiving ports 20. Each sample receiving port may have an electrode 30, a counter electrode 40, and areference electrode 50. Thereference electrode 50 may provide for a fill indication, as it will only pass a voltage when the sample reaches theelectrode 50. The 70, 80 are also visible, which interconnect with the electrodes and connect to contacts in the meter when inserted. The strip size does not change depending on the number of assays.contacts FIG. 5 displays a separate blood sampling port for each assay. Some embodiments may include separate sampling ports, particularly if there could be “cross talk” between reagents.FIG. 6 shows an embodiment with a single sampling port. In many embodiments, there will be asingular sampling port 210 for the multi-analyte panels. Again, this strip allows for adaptability of design to meet the needs of particular assays. As shown in the left-most strip, asingle sample port 210 may provide for five different sets of contacts, providing for the testing of five different analyte tests. Various combinations of analytes may be used in the strips as described herein. In some embodiments, a central application point is available for the sampler. This eases the challenge of dosing a large number of ports. As shown inFIG. 7 , a possible geometry for such a configuration is shown.Test strip 710 includes a receivingport 720, similar to receivingport 410 ofFIG. 4 . The receivingport 720 is sized in a complementary fashion to that of a sampler that may include a premix set. The receivingport 720 includes tubes 730 (typically capillary tubes) for extracting a portion of the sample. Also shown are thecontact wires 740, the connect to the electrodes that are typically located in thetubes 730. The arrangement shown is only one possible arrangement for a receiving port with multiple interconnected capillary channels. A large number of geometries are possible. Additionally, in some embodiments, the receivingport 720 may include a first and second set point. When the sampler is inserted and pushed to the first set point in the receivingport 720, the sample may be distributed to thetubes 730. After distribution, the sampler may be further advanced to separate the sampler from the sample contained in thetubes 730. In such a scenario receiving port may include breakaway tabs at the first set point through which the user may push the sampler, in order to reach the second set point, whereby fluidic communication between the sample in the tubes is lessened. This may decrease cross talk. - The pyruvate reaction pathway may apply to the detection of other analytes as well. For instance, in one embodiment, this phosphate may react in a similar fashion. The pyruvate reaction where pyruvate oxidase from E. Coli reacts with the mediator for an electrochemical ALT and AST assay (see reaction below) can be used for an electrochemical detection scheme.
- Therefore, it is also possible to have an electrochemical phosphate assay. By providing the pyruvate, ferricyanide, and pyruvate oxidase, one can easily develop an electrochemical phosphate assay. A phosphate assay would be an excellent companion assay with a Vitamin D test. It also could be used in a non-medical application in water testing. One challenge is that many pyruvate oxidase enzymes have been lyophilized from a phosphate buffer. A pyruvate oxidase enzyme that is not provided in a phosphate buffer is needed in some embodiments to complete this assay.
- In conclusion, embodiments for an electrochemical ALT, AST, and phosphate sensor are provided herein. An electrochemical point-of-care ALT/AST test does not previously exist. The ALT and AST tests could be beneficial to those taking medications which could possibly impair liver function. It also may be used in small clinics to determine levels of ALT or AST for further medical diagnosis. Furthermore, having an electrochemical phosphate assay could be used as a companion diagnostic to a Vitamin D assay or a stand-alone test.
- While specific embodiments have been described in detail in the foregoing detailed description and illustrated in the accompanying drawings, it will be appreciated by those skilled in the art that various modifications and alternatives to those details could be developed in light of the overall teachings of the disclosure and the broad inventive concepts thereof. It is understood, therefore, that the scope of this disclosure is not limited to the particular examples and implementations disclosed herein but is intended to cover modifications within the spirit and scope thereof as defined by the appended claims and any and all equivalents thereof.
Claims (17)
1. A system for electrochemically detecting ALT, the system comprising:
a sampler for producing pyruvate from ALT;
an electrochemical test strip for receiving a processed sample from the sampler, the processed sample containing pyruvate; and
a meter for reading the electrochemical test strip and indicating an amount of ALT in the sample.
2. The system of claim 1 , wherein the sampler contains L-Alanine+alpha-Ketoglutarate.
3. The system of claim 2 , wherein the electrochemical test strip includes phosphate and ferricyanide.
4. The system of claim 3 , wherein the electrochemical test strip further includes pyruvate oxidase.
5. The system of claim 4 , wherein the sampler includes a heating element.
6. The system of claim 4 , wherein the electrochemical test strip includes a heating element.
7. The system of claim 5 , wherein the sampler includes a timer.
8. The system of claim 5 , wherein the meter includes a timer.
9. A system for electrochemically detecting AST, the system comprising:
a sampler for producing pyruvate from AST;
an electrochemical test strip for receiving a processed sample from the sampler, the processed sample containing pyruvate; and
a meter for reading the electrochemical test strip and indicating an amount of AST in the sample.
10. The system of claim 9 , wherein the sampler contains L-Aspartic acid+alpha-Ketoglutarate.
11. The system of claim 10 , wherein the sampler further contains oxaloacetate decarboxylase.
12. The system of claim 11 , wherein the electrochemical test strip includes phosphate and ferricyanide.
13. The system of claim 12 , wherein the electrochemical test strip further includes pyruvate oxidase.
14. The system of claim 13 , wherein the sampler includes a heating element.
15. The system of claim 13 , wherein the electrochemical test strip includes a heating element.
16. The system of claim 14 , wherein the sampler includes a timer.
17. The system of claim 14 , wherein the meter includes a timer.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US16/176,056 US20190062801A1 (en) | 2015-12-28 | 2018-10-31 | Systems and methods for electrochemical aspartate transaminase (ast) and alanine transaminase (alt) detection and quantification |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562271753P | 2015-12-28 | 2015-12-28 | |
| US15/392,593 US10144949B2 (en) | 2015-12-28 | 2016-12-28 | Systems and methods for electrochemical aspartate transaminase (AST) and alanine transaminase (ALT) detection and quantification |
| US16/176,056 US20190062801A1 (en) | 2015-12-28 | 2018-10-31 | Systems and methods for electrochemical aspartate transaminase (ast) and alanine transaminase (alt) detection and quantification |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US15/392,593 Division US10144949B2 (en) | 2015-12-28 | 2016-12-28 | Systems and methods for electrochemical aspartate transaminase (AST) and alanine transaminase (ALT) detection and quantification |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| US20190062801A1 true US20190062801A1 (en) | 2019-02-28 |
Family
ID=59086208
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US15/392,593 Active US10144949B2 (en) | 2015-12-28 | 2016-12-28 | Systems and methods for electrochemical aspartate transaminase (AST) and alanine transaminase (ALT) detection and quantification |
| US16/176,056 Abandoned US20190062801A1 (en) | 2015-12-28 | 2018-10-31 | Systems and methods for electrochemical aspartate transaminase (ast) and alanine transaminase (alt) detection and quantification |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US15/392,593 Active US10144949B2 (en) | 2015-12-28 | 2016-12-28 | Systems and methods for electrochemical aspartate transaminase (AST) and alanine transaminase (ALT) detection and quantification |
Country Status (2)
| Country | Link |
|---|---|
| US (2) | US10144949B2 (en) |
| WO (1) | WO2017117231A1 (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11338294B2 (en) | 2017-04-27 | 2022-05-24 | Polybiomics, Inc. | Orthogonal polybiosensing and imaging systems |
| CN110133079A (en) * | 2019-04-25 | 2019-08-16 | 广州万孚生物技术股份有限公司 | Glutamic-oxalacetic transaminease Electrochemical Detection composition, its application, electrochemical sensor and detection method |
| US12252728B2 (en) | 2019-09-17 | 2025-03-18 | Nova Biomedical Corporation | Systems and methods for measuring liver enzyme levels in blood |
| AU2023260645A1 (en) | 2022-04-28 | 2024-09-19 | Société des Produits Nestlé S.A. | Methods of determining a health status of a cat based on one or more biomarkers, and methods of treating a mortality risk identified by the health status |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6878251B2 (en) | 1998-03-12 | 2005-04-12 | Lifescan, Inc. | Heated electrochemical cell |
| GB0313015D0 (en) | 2003-06-06 | 2003-07-09 | Hall Effect Technologies Ltd | Method and device for analysing a liquid |
| US20110318755A1 (en) | 2008-12-15 | 2011-12-29 | Piasio Roger N | Universal Testing Platform for Medical Diagnostics |
| TWM375871U (en) * | 2009-08-21 | 2010-03-11 | Apex Biotechnology Corp | Biochemical test strip, measurement device, and biochemical test system |
| KR101954957B1 (en) | 2011-07-27 | 2019-06-12 | 아가매트릭스, 인코포레이티드 | Reagents for electrochemical test strips |
| US9180455B2 (en) | 2011-08-16 | 2015-11-10 | Polymer Technology Systems, Inc. | Vent configuration for a blood sampler |
-
2016
- 2016-12-28 US US15/392,593 patent/US10144949B2/en active Active
- 2016-12-28 WO PCT/US2016/068894 patent/WO2017117231A1/en not_active Ceased
-
2018
- 2018-10-31 US US16/176,056 patent/US20190062801A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US20170183711A1 (en) | 2017-06-29 |
| WO2017117231A1 (en) | 2017-07-06 |
| US10144949B2 (en) | 2018-12-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20240269672A1 (en) | Devices and Methods for Modifying Optical Properties | |
| US20190062801A1 (en) | Systems and methods for electrochemical aspartate transaminase (ast) and alanine transaminase (alt) detection and quantification | |
| US8712701B2 (en) | Potentiometric-sensor chip, potentiometric assay, and assay kit | |
| US10591495B2 (en) | Device and methods of using device for detection of hyperammonemia | |
| KR20130014053A (en) | Electrochemical analyte measurement method and system | |
| CN105699449A (en) | Multiple-analyte assay device and system | |
| Bai et al. | A portable all-in-one microfluidic device with real-time colorimetric LAMP for HPV16 and HPV18 DNA point-of-care testing | |
| Young | Evolution of blood chemistry analyzers based on ion selective electrodes | |
| Mizukami et al. | Electrochemical enzyme-based blood ATP and lactate sensor for a rapid and straightforward evaluation of illness severity | |
| CN206876623U (en) | A kind of Electrochemical blood glucose biology sensor with packed cell volume calibration function | |
| EP3589948A1 (en) | Systems and methods for enzymatic a1c detection and quantification | |
| AU2013322547A1 (en) | System and method for determining hematocrit insensitive glucose concentration | |
| EP2297574B1 (en) | Bio-sensor | |
| CN101127792B (en) | Mobile communication terminal with temperature compensation function for use in biological information measurement | |
| US11703513B2 (en) | Systems and methods for enzymatic A1C detection and quantification | |
| US6818415B2 (en) | Sodium activation of amylase | |
| CN113252653A (en) | Method for detecting physiologically active substance and detection tool | |
| Chen et al. | Disposable glucose test strip for whole blood with integrated sensing/diffusion-limiting layer | |
| Santos et al. | 18 Biomolecules in Analytical Methods | |
| Santos et al. | Biomolecules in Analytical Methods | |
| Kumahor et al. | Electrolyte Potentiometers in Medical Diagnosis: From Bench to Bedside | |
| Gourmelin et al. | Electrode measurement of glucose and urea in undiluted samples | |
| KR0166866B1 (en) | Fiber optic biosensor | |
| CN119000572A (en) | Preparation method and application of three-mode optical sensor based on silver ion-OPD system | |
| Mackenzie et al. | Evaluation of an automated colorimetric assay for the measurement of lipase activity in canine sera |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AS | Assignment |
Owner name: POLYMER TECHNOLOGY SYSTEMS, INC., INDIANA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:HUGHES, GARY L;PATWARDHAN, ANIRUDDHA;SIGNING DATES FROM 20151229 TO 20160106;REEL/FRAME:047368/0421 |
|
| STPP | Information on status: patent application and granting procedure in general |
Free format text: APPLICATION DISPATCHED FROM PREEXAM, NOT YET DOCKETED |
|
| STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
| STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
| STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |